Total Return chart COSCIENS Biopharma Inc.

Stocks

Delayed Toronto S.E. Other stock markets 13:14:08 2026-07-16 EDT			5-day change	1st Jan Change
8.000 ^CAD	+0.38%		-32.20%	-6.10%

07-03	COSCIENS Biopharma Completes Share Capital Amendment	MT
06-18	Cosciens Biopharma Inc. Announces Appointment of Peter H. Puccetti as Permanent CEO, Effective June 18, 2026	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.